# Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

Study · id `cardio:ct-nct06697314` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06697314](<https://clinicaltrials.gov/study/NCT06697314>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06697314

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 256 participants.

## Technical summary

Registry record NCT06697314. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-15 (actual); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 256 participants (planned count; ClinicalTrials.gov record NCT06697314, source copy `cardio:ctgov-nct06697314-2025-09-26`, retrieved 2026-10-31)
- Started: 2025-06-15 (actual) (ClinicalTrials.gov record NCT06697314, source copy `cardio:ctgov-nct06697314-2025-09-26`, retrieved 2026-10-31)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT06697314, source copy `cardio:ctgov-nct06697314-2025-09-26`, retrieved 2026-10-31)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT06697314, source copy `cardio:ctgov-nct06697314-2025-09-26`, retrieved 2026-10-31)
- Countries: Poland (ClinicalTrials.gov record NCT06697314, source copy `cardio:ctgov-nct06697314-2025-09-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06697314-2025-09-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- Acronym: RECOVER-AV
- Condition: Acute Pulmonary Embolism (PE)
- Condition: Pulmonary Embolism
- Intervention (Device): AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- Lead sponsor: Angiodynamics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Angiodynamics, Inc. (`cardio:org-angiodynamics-inc`)

## Provenance

Content hash: 774246b366023bfb83dac84f361b44ac6ebab8aa26e28bf78956a2c30953f1f9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
